Li Kang Biomedical Co Stock

Li Kang Biomedical Co Forward P/E

The Forward P/E Ratio of Li Kang Biomedical Co (6242.TWO) as of Aug 8, 2026 is 14.53. In the previous year, Forward P/E Ratio was 15.82 — a change of -8.11% (lower).

Forward P/E

14.53

YoY

-8.11%

Last updated:

Forward P/E Ratio of Li Kang Biomedical Co is 2026 14.53 . Forward P/E Ratio of Li Kang Biomedical Co was 2025 15.82 . It decreases by -8.11% lower compared to the previous year.
Access this data via the Eulerpool API

Li Kang Biomedical Co Stock analysis

What does Li Kang Biomedical Co do? Li Kang Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Li Kang Biomedical Co stock

Forward P/E Ratio of Li Kang Biomedical Co is 14.53 in 2026.

Forward P/E Ratio of Li Kang Biomedical Co changed from 15.82 to 14.53, representing a -8.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Li Kang Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Li Kang Biomedical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Li Kang Biomedical Co

All Key Metrics — Li Kang Biomedical Co